Compare Almirall SA with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-96.51%
0%
-96.51%
6 Months
-96.51%
0%
-96.51%
1 Year
-96.51%
0%
-96.51%
2 Years
-96.51%
0%
-96.51%
3 Years
-93.25%
0%
-93.25%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Almirall SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.15%
EBIT Growth (5y)
21.66%
EBIT to Interest (avg)
-7.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.39
Tax Ratio
25.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.99%
ROCE (avg)
4.32%
ROE (avg)
24.28%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
1.64
EV to EBIT
49.73
EV to EBITDA
18.97
EV to Capital Employed
1.66
EV to Sales
3.47
PEG Ratio
NA
Dividend Yield
1.58%
ROCE (Latest)
3.34%
ROE (Latest)
7.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot : Mar 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.97%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'16 - YoY
Mar'16
Mar'15
Change(%)
Net Sales
184.90
180.00
2.72%
Operating Profit (PBDIT) excl Other Income
38.70
35.40
9.32%
Interest
4.70
2.70
74.07%
Exceptional Items
0.00
0.00
Consolidate Net Profit
21.70
42.90
-49.42%
Operating Profit Margin (Excl OI)
88.20%
92.80%
-0.46%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2016 is 2.72% vs -10.71% in Mar 2015
Consolidated Net Profit
YoY Growth in quarter ended Mar 2016 is -49.42% vs 304.72% in Mar 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,108.10
985.70
12.42%
Operating Profit (PBDIT) excl Other Income
218.90
184.60
18.58%
Interest
17.90
16.40
9.15%
Exceptional Items
11.60
-10.00
216.00%
Consolidate Net Profit
46.20
10.10
357.43%
Operating Profit Margin (Excl OI)
61.10%
46.10%
1.50%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 12.42% vs 10.20% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 357.43% vs 126.23% in Dec 2024
About Almirall SA 
Almirall SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






